The Latest Cardiac and Vascular News
WEST CHESTER, Pa., May 11, 2022 /PRNewswire/ — VESTECK, Inc. is pleased to announce their participation and strong podium presence at the Charring Cross International Vascular Symposium. “Charring Cross” (CX), held annually in London, UK, is considered one of the premier global Vascular/Endovascular symposiums. Key Opinion Leaders from around the world assemble to […]
WARREN, N.J., May 11, 2022 (GLOBE NEWSWIRE) — Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary diseases, today provided a clinical program update and reported financial results for the first quarter ended March 31, 2022. “We remain focused on […]
Increased commercial momentum and great interest in CADScor® System on the US market 2022 has started off positiv with important steps on the US market, recruitment of key staff and continued validation that our business model works. We report doubled sales of patches compared with the corresponding quarter of 2021. […]
SPARKS, Md., May 10, 2022 (GLOBE NEWSWIRE) — TridentCare, a national leader of portable diagnostic services, announces its new partnership with Harness Health Partners to provide mobile X-ray, Ultrasound and EKG services across the United States. “This is an exciting time for TridentCare,” says TridentCare CEO David Velez. “We are excited […]
Westport, CT, May 11, 2022 (GLOBE NEWSWIRE) — To date, Company’s FDA 510(k) cleared PURE EP(TM) system has completed over 2,200 patient cases with 75 physicians at 17 hospitals across the United States The Company adds new executives to accelerate sustained commercial momentum developing a national installed base of the PURE EP […]
NAARDEN, Netherlands & MIAMI–(BUSINESS WIRE)–NewAmsterdam Pharma (NewAmsterdam), a clinical-stage company focused on the research and development of transformative therapies for metabolic diseases, today announced the publication of a new meta-analysis in the European Heart Journal’s publication Cardiovascular Pharmacotherapy, discussing the effect of cholesteryl ester transfer protein (CETP) inhibitors on new-onset diabetes. […]
PARIS–(BUSINESS WIRE)–Regulatory News: CARMAT (FR0010907956, ALCAR), the designer and developer of the world’s most advanced total artificial heart, aiming to fulfill an unmet medical need by providing a therapeutic alternative to people suffering from end-stage biventricular heart failure, informs its shareholders that the annual general meeting (AGM) of May 11, […]
Company Is Committed to Innovation for Patients Living With Heart Failure MARLTON, N.J., May 10, 2022 (GLOBE NEWSWIRE) — Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure (HF), is announcing today the first implants of its newly launched Optimizer® Smart Mini, […]
Cardiovascular study results to be presented by Prof. Ran Kornowski, Director of the Cardiology Center, Rabin Medical Center at the EuroPCR 2022 conference in May CAESAREA, Israel, May 10, 2022 /PRNewswire/ — Filterlex Medical Ltd., a cardiovascular medical device startup, announced today that it has completed its CAPTIS First-In-Human (FIH) study. Study results […]
– The eTrieve™ catheter for removing blood clots, based on electric fields, met safety and feasibility endpoints – Data, showing significant reduction RV/LV ratio and alleviation of PE associated symptoms, presented at Biomed Israel 2022 OR YEHUDA, Israel, May 10, 2022 /PRNewswire/ — Magneto Thrombectomy Solutions (Magneto), a medical devices company developing innovative thrombectomy solutions for the […]
